Advertisement
Review article| Volume 27, ISSUE 4, P246-252, June 2005

Download started.

Ok

Down syndrome, Alzheimer's disease and seizures

      Abstract

      Neuropathologically, Alzheimer-type abnormalities are demonstrated in patients with Down syndrome (DS), both demented and nondemented and more than a half of patients with DS above 50 years develop Alzheimer's disease (AD). The apolipoprotein E epsilon4 allele, oestrogen deficiency, high levels of Aβ1–42 peptide, elevated expression of BACE2, and valine polymorphism of prion protein gene are associated with earlier onset of dementia in DS individuals. Advanced AD alone may be an important risk factor for new-onset seizures in older adults and age above 60 years is a recognized risk factor for poor outcome from convulsive and nonconvulsive status epilepticus. DS patients aged over 45 years are significantly more likely to develop Alzheimer's disease than those less than 45 years and up to 84% demented individuals with DS develop seizures. Late-onset epilepsy in DS is associated with AD, while early-onset epilepsy is associated with an absence of dementia. In AD patients with a younger age of dementia onset are particularly susceptible to seizures. DS adults with epilepsy score significantly higher overall on the adaptive behaviour profile. Language function declined significantly more rapidly in AD patients with seizures and there is a good correlation between the severity of EEG abnormalities and cognitive impairment whereas in DS slowing of the dominant occipital rhythm is related to AD and the frequency of the dominant occipital activity decreases at the onset of cognitive deterioration.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lai F.
        • Williams R.S.
        A prospective study of Alzheimer disease in Down syndrome.
        Arch Neurol. 1989; 46: 849-853
        • Schupf N.
        • Sergievsky G.H.
        Genetic and host factors for dementia in Down's syndrome.
        Br J Psychiatry. 2002; 180: 405-410
        • Raghavan R.
        • Khin-Nu C.
        • Brown A.G.
        • Day K.A.
        • Tyrer S.P.
        • Ince P.G.
        • et al.
        Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21).
        NeuroReport. 1994; 5: 1393-1396
        • Schupf N.
        • Pang D.
        • Patel B.N.
        • Silverman W.
        • Schubert R.
        • Lai F.
        • et al.
        Onset of dementia is associated with age at menopause in women with Down's syndrome.
        Ann Neurol. 2003; 54: 433-438
        • Hyman B.T.
        • West H.L.
        • Rebeck G.W.
        • Buldyrev S.V.
        • Mantegna R.N.
        • Ukleja M.
        • et al.
        Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
        Proc Natl Acad Sci USA. 1995; 92: 3586-3590
        • Folin M.
        • Baiguera S.
        • Conconi M.T.
        • Pati T.
        • Grandi C.
        • Parnigotto P.P.
        • Nussdorfer G.G.
        The impact of risk factors of Alzheimer's disease in the Down syndrome.
        Int J Mol Med. 2003; 11: 267-270
        • Motonaga K.
        • Itoh M.
        • Becker L.E.
        • Goto Y.
        • Takashima S.
        Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome.
        Neurosci Lett. 2002; 326: 64-66
        • Del Bo R.
        • Comi G.P.
        • Giorda R.
        • Crimi M.
        • Locatelli F.
        • Martinelli-Boneschi F.
        • et al.
        The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects.
        J Neurol. 2003; 250: 688-692
        • Evenhuis H.M.
        The natural history of dementia in Down's syndrome.
        Arch Neurol. 1990; 47: 263-267
        • Hirayama A.
        • Horikoshi Y.
        • Maeda M.
        • Ito M.
        • Takashima S.
        Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome.
        Brain Dev. 2003; 25: 180-185
        • Mehta P.D.
        • Mehta S.P.
        • Fedor B.
        • Patrick B.A.
        • Emmerling M.
        • Dalton A.J.
        Plasma amyloid beta protein 1–42 levels are increased in old Down syndrome but not in young Down syndrome.
        Neurosci Lett. 2003; 342: 155-158
        • Cataldo A.M.
        • Peterhoff C.M.
        • Troncoso J.C.
        • Gomez-Isla T.
        • Hyman B.T.
        • Nixon R.A.
        Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
        Am J Pathol. 2000; 157: 277-286
        • Hyman B.T.
        • West H.L.
        • Rebeck G.W.
        • Lai F.
        • Mann D.M.
        Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
        Arch Neurol. 1995; 52: 373-378
        • Patel P.
        • Goldberg D.
        • Moss S.
        Psychiatric morbidity in older people with moderate and severe learning disability. II. The prevalence study.
        Br J Psychiatry. 1993; 163: 481-491
        • Krasuski J.S.
        • Alexander G.E.
        • Horwitz B.
        • Rapoport S.I.
        • Schapiro M.B.
        Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
        Am J Psychiatry. 2002; 159: 74-81
        • Pinter J.D.
        • Brown W.E.
        • Eliez S.
        • Schmitt J.E.
        • Capone G.T.
        • Reiss A.L.
        Amygdala and hippocampal volumes in children with Down syndrome: a highresolution MRI study.
        Neurology. 2001; 56: 972-974
        • Fowler A.
        Language abilities in children with Down syndrome: evidence for a specific syntactic delay.
        in: Cicchetti D. Beeghly M. Down syndrome: a developmental perspective. Cambridge University Press, Cambridge, UK1990: 302-328
        • Strydom A.
        • Hassiotis A.
        Diagnostic instruments for dementia in older people with intellectual disability in clinical practice.
        Aging Ment Health. 2003; 7: 431-437
        • Hauser W.A.
        • Morris M.L.
        • Heston L.L.
        • Anderson V.E.
        Seizures and myoclonus in patients with Alzheimer's disease.
        Neurology. 1986; 36: 1226-1230
        • Romanelli M.F.
        • Morris J.C.
        • Ashkin K.
        • Coben L.A.
        Advanced Alzheimer's disease is a risk factor for late-onset seizures.
        Arch Neurol. 1990; 47: 847-850
        • Armon C.
        • Peterson G.W.
        • Liwnicz B.H.
        Alzheimer's disease underlies some cases of complex partial status epilepticus.
        J Clin Neurophysiol. 2000; 17: 511-518
        • Despland P.A.
        Dementia and late epileptic seizures.
        Schweiz Rundsch Med Prax. 1997; 86: 1414-1417
        • Stam C.J.
        • van der Made Y.
        • Pijnenburg Y.A.
        • Scheltens P.
        EEG synchronization in mild cognitive impairment and Alzheimer's disease.
        Acta Neurol Scand. 2003; 108: 90-96
        • Kowalski J.W.
        • Gawel M.
        • Pfeffer A.
        • Barcikowska M.
        The diagnostic value of EEG in Alzheimer disease: correlation with the severity of mental impairment.
        J Clin Neurophysiol. 2001; 18: 570-575
        • Mendez M.F.
        • Catanzaro P.
        • Doss R.C.
        • Arguello R.
        • Frey II, W.H.
        Seizures in Alzheimer's disease: clinicopathologic study.
        J Geriatr Psychiatry Neurol. 1994; 7: 230-233
        • Diaz-Arrastia R.
        • Gong Y.
        • Fair S.
        • Scott K.D.
        • Garcia M.C.
        • Carlile M.C.
        • et al.
        Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele.
        Arch Neurol. 2003; 60: 818-822
        • Volicer L.
        • Smith S.
        • Volicer B.J.
        Effect of seizures on progression of dementia of the Alzheimer type.
        Dementia. 1995; 6: 258-263
        • Romano C.
        • Tine A.
        • Fazio G.
        • Rizzo R.
        • Colognola R.M.
        • Sorge G.
        • et al.
        Seizures in patients with trisomy 21.
        Am J Med Genet Suppl. 1990; 7: 298-300
        • Pueschel S.M.
        • Louis S.
        • McKnight P.
        Seizure disorders in Down syndrome.
        Arch Neurol. 1991; 48: 318-320
        • Moller J.C.
        • Hamer H.M.
        • Oertel W.H.
        • Rosenow F.
        Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).
        Seizure. 2002; 11: 303-305
        • Puri B.K.
        • Ho K.W.
        • Singh I.
        Age of seizure onset in adults with Down's syndrome.
        Int J Clin Pract. 2001; 55: 442-444
        • Stafstrom C.E.
        • Konkol R.J.
        Infantile spasms in children with Down syndrome.
        Dev Med Child Neurol. 1994; 36: 576-585
        • Eisermann M.M.
        • DeLaRaillere A.
        • Dellatolas G.
        • Tozzi E.
        • Nabbout R.
        • Dulac O.
        • et al.
        Infantile spasms in Down syndrome—effects of delayed anticonvulsive treatment.
        Epilepsy Res. 2003; 55: 21-27
        • Escofet C.
        • Poo P.
        • Valbuena O.
        • Gassio R.
        • Sanmarti F.X.
        • Campistol J.
        Infantile spasms in children with Down's syndrome.
        Rev Neurol. 1995; 23: 315-317
        • Goldberg-Stern H.
        • Strawsburg R.H.
        • Patterson B.
        • Hickey F.
        • Bare M.
        • Gadoth N.
        • et al.
        Seizure frequency and characteristics in children with Down syndrome.
        Brain Dev. 2001; 23: 375-378
        • Prasher V.P.
        Epilepsy and associated effects on adaptive behaviour in adults with Down syndrome.
        Seizure. 1995; 4: 53-56
        • Caplan R.
        • Austin J.K.
        Behavioral aspects of epilepsy in children with mental retardation.
        Ment Retard Dev Disabil Res Rev. 2000; 6: 293-299
        • Politoff A.L.
        • Stadter R.P.
        • Monson N.
        • Hass P.
        Cognition-related EEG abnormalities in nondemented Down syndrome subjects.
        Dementia. 1996; 7: 69-75
        • Soininen H.
        • Partanen J.
        • Jousmaki V.
        • Helkala E.L.
        • Vanhanen M.
        • Majuri S.
        • et al.
        Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease.
        Neuroscience. 1993; 53: 57-63
        • Visser F.E.
        • Kuilman M.
        • Oosting J.
        • Overweg J.
        • van Wijk J.
        • van Huffelen A.C.
        Use of electroencephalography to detect Alzheimer's disease in Down's syndrome.
        Acta Neurol Scand. 1996; 94: 97-103
        • Ono Y.
        EEG changes with aging in adults with Down syndrome.
        Jpn J Psychiatry Neurol. 1993; 47: 75-84
        • Katada A.
        • Hasegawa S.
        • Ohira D.
        • Kumagai T.
        • Harashima T.
        • Ozaki H.
        • et al.
        On chronological changes in the basic EEG rhythm in persons with Down syndrome—with special reference to slowing of alpha waves.
        Brain Dev. 2000; 22: 224-229